Companies: 10,795·Total market cap: $144.5T
Lexaria Bioscience Corp.

Lexaria Bioscience Corp.

LEXXNASDAQHealthcare● Active
$0.65
+$0.01(+1.51%)
Market Cap$13219377
P/E Ratio
52W High$1.55
52W Low$0.46

Lexaria Bioscience Corp.(LEXX)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · LEXX · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-082024-082023-082022-082021-08
Revenue
Revenue$0.71M$0.46M$0.23M$0.26M$0.72M
Cost of Revenue$0.00M$0.00M$0.03M$0.07M$0.18M
Gross Profit$0.70M$0.46M$0.19M$0.18M$0.55M
Gross Margin %(computed)99.61%98.96%86.07%71.87%75.74%
Operating Expenses
R&D Expenses$8.24M$2.36M$3.67M$1.84M$1.26M
G&A Expenses$4.35M$3.85M$3.06M$4.96M$4.97M
Total Operating Expenses$12.58M$6.21M$6.73M$6.80M$6.23M
Operating Income($11.88M)($5.75M)($6.53M)($6.62M)($5.69M)
Operating Margin %(computed)-786.85%
Interest Income$0.00M$0.01M$0.04M$0.00M$0.00M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($11.91M)($5.81M)($6.71M)($7.38M)($4.16M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($11.90M)($5.80M)($6.66M)($7.27M)($4.03M)
Net Margin %(computed)-557.19%
Per Share & EBITDA
EPS (Basic)$-0.66$-0.47$-1.01$-1.24$-0.92
Wtd Avg Shares18.00M12.38M6.61M5.89M4.39M
EBITDA($11.79M)($5.68M)($6.39M)($6.52M)($5.54M)
EBITDA Margin %(computed)-766.43%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Lexaria Bioscience Corp.

关于Lexaria Bioscience Corp.(LEXX)损益表

Lexaria Bioscience Corp.(LEXX)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,LEXX实现营收$0.00B,毛利润$0.00B(毛利率99.61%),净利润($0.01B)(净利率-1686.00%)。

常见问题

LEXX · 4 问

Lexaria Bioscience Corp.(LEXX)2025财年营收为$0.00B,同比up52.0%。

LEXX revenueLEXX salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09